Intensity-Modulated Radiation Therapy (IMRT)
Customize your policy alerts
Sign up for healthfirstofnewyork Policy PO-RE-123v2 alerts
Get alerted when Policy PO-RE-123v2 changes without checking for updates manually.
Monitor payer policy activity
This policy governs reimbursement of IMRT and related radiation oncology services submitted by healthcare providers to Healthfirst. Coverage and payment depend on applicable clinical indications, qualifying diagnoses, member benefits, provider contracts, and the applicable line of business.
An adjudication and appeal process section was added.
Coverage and Reimbursement Requirements
Qualifying Clinical Indications and Diagnoses
IMRT coverage is limited to the specified clinical indications below, unless the treatment is re-irradiation for a previously radiated cancer.
IMRT services must meet all applicable requirements
A qualifying clinical indication is present
Qualifying diagnoses
- Malignant neoplasm of the anal canal (C21.1).
- Malignant neoplasm of the lip (C00.0-C00.4, C00.6, C00.8).
- Cerebral or spinal meningioma (D32.0-D32.1).
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.